Who are the key players in China Intrauterine Devices industry?

The top five players in the China intrauterine devices market include Anhui Tianda, Shanghai Medical Instruments, Shandong Qiaopai Group, Suzhou Suning Healthcare Products, and Henan Xinxiang Medical Device. These companies lead the market with strong regional distribution networks and innovative product portfolios, driving significant market share.

What is the China Intrauterine Devices growth?

The China intrauterine devices market has shown notable growth, with a CAGR of over 6% in recent years. For example, Anhui Tianda has expanded its product sales due to increasing awareness of long-term contraception and supportive government family planning policies.

Which segment accounted for the largest China Intrauterine Devices share?

The hospital segment holds the largest share of China’s intrauterine devices market. Hospitals remain the preferred point for IUD insertion owing to the presence of skilled medical professionals, standardized procedures, and reliable patient follow-up, which ensures higher safety and adoption rates.

What are the factors driving the China Intrauterine Devices?

Key factors driving the China intrauterine devices market include increasing awareness about birth control, government initiatives promoting family planning, and improved device safety. Companies like Shandong Qiaopai Group have benefited from public health campaigns encouraging the use of IUDs due to their effectiveness and convenience.

Which type accounted for the largest China Intrauterine Devices share?

Copper IUDs accounted for the largest market share in China, favored for their long-term efficacy, affordability, and minimal hormonal side effects. Products by Suzhou Suning Healthcare Products have become especially popular due to their reliability and widespread availability within hospital procurement channels.

Home Medical Devices

China Intrauterine Devices Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

Name: China Intrauterine Devices
Brand: Bussiness Insights

China Intrauterine Devices Market: by Type (Copper IUDs, Hormonal IUDs), Application (Contraception, Menorrhagia, Dysmenorrhea, Emergency Contraception, Others), Distribution Channels (Hospitals, Clinics, Retail Pharmacies, Online Pharmacies, Others), Technology (Conventional IUDs, Smart IUDs), Organization Size (Small, Medium, Large) and By China Historical & Forecast Period (2020-2035) Comprehensive Study 2025

Last Updated: 31-07-2025 | Format: PDF | Report ID:20221 | Author: Ankita R

RD TOC Segmentation Research Methodology Request For Free Sample Copy

China Intrauterine Devices Market Outlook (2025-2035)

The China Intrauterine Devices (IUD) market is experiencing robust growth and technological advancements, driven by increasing awareness of long-term contraception options and healthcare reforms. The market includes a wide range of products, including copper, hormonal, biodegradable, and smart IUDs, serving diverse applications such as contraception, menorrhagia, and endometriosis. Major market players are innovating to deliver safer, more effective IUDs tailored for both clinical and retail settings. As China’s population policy shifts and women’s health initiatives strengthen, demand for modern contraceptives—especially IUDs—continues to rise, positioning the country as a key market for global and domestic manufacturers.

Latest Market Dynamics

Key Drivers

Growing awareness of women's reproductive health and government initiatives promoting family planning have led to a surge in IUD adoption across China. Bayer AG is expanding its Mirena hormonal IUD distribution network to meet rising consumer demand, leveraging educational campaigns and collaborations with hospitals.

Adoption of smart IUDs with digital health integration is emerging, enabling remote monitoring and personalized follow-ups. CooperSurgical Inc. introduced RFID-enabled IUDs in partnership with Chinese hospitals, improving patient compliance and safety tracking.
Biodegradable and hormone-releasing IUDs are gaining traction due to rising concerns about side effects and the demand for environmentally sustainable solutions. OCON Healthcare recently received approval for a biodegradable IUD prototype in two pilot cities.

Expansion into untapped rural regions, where access to contraceptive care remains low, represents a major growth avenue. Lifecare Devices Pvt. Ltd. initiated rural outreach programs with mobile clinics and provided subsidized IUDs, accelerating market penetration.
E-commerce and online pharmacy platforms experience surging IUD sales, especially among younger, urban women. DKT International strengthened its presence via JD Health’s digital health marketplace, offering product education and teleconsultations.

Cultural barriers and misconceptions still limit market growth in certain demographics, slowing adoption rates. HLL Lifecare Limited has implemented strategic awareness campaigns targeting conservative communities but faces ongoing resistance.
Competition from other methods of contraception—including oral contraceptives and implants—poses a challenge to IUD market share. Pregna International Ltd. has diversified its portfolio to remain competitive, but brand switching among consumers persists.

Stringent post-market surveillance and adverse event reporting regulations increase compliance costs for manufacturers. Sichuan Qianjin Technology Co. Ltd. reported higher post-approval monitoring expenses in 2024, impacting profit margins.
Concerns about side effects and insertion pain deter some women from opting for IUDs. SMB Corporation of India has focused heavily on physician training and product improvements, but overcoming patient apprehension remains a key restraint.

The IUD market in China is dominated by Copper IUDs, capturing the largest segment due to their cost-effectiveness and high efficacy. Hormonal IUDs are rapidly gaining ground, driven by growing awareness of their therapeutic benefits for menstrual disorders. Biodegradable, inert, and dual-function IUDs, though representing smaller shares, are increasingly adopted as consumers seek more advanced and safer alternatives. Ongoing innovation and strategic alliances by leading companies are broadening product access in both public and private healthcare sectors.

Contraception remains the primary application of IUDs in China, comprising the majority share of the market. IUD adoption for managing menorrhagia and dysmenorrhea is on the rise, as awareness spreads regarding therapeutic uses beyond contraception. Emergency contraception and endometriosis management account for smaller shares but represent growing opportunities. Leading players are increasing investments in clinical trials and partnerships to expand the use-cases of IUDs and address a wider spectrum of women’s health needs.

The market revenue for intrauterine devices in China has shown consistent growth from 2020 and is projected to accelerate through 2035. In 2025, the market size is anticipated to reach approximately $790 million, up from $680 million in 2021, driven by rising adoption rates, broader product availability, and government health initiatives. The growth trajectory points to sustained demand, fueled by new product launches, regulatory reforms, and expanded patient accessibility. Companies are strategically scaling operations to capture incremental revenue streams and strengthen their China market position.

Year-over-year growth in the China IUD market remains robust, averaging 8-10% between 2020 and 2025. Growth rates are forecasted to slightly moderate to around 7% post-2025 as the market reaches greater maturity and urban saturation. Key factors supporting sustained growth include increased public health investments, continuous innovation from leading vendors, and effective awareness campaigns. The market is also marked by positive fluctuations in YOY performance driven by technology upgrades and emerging use cases beyond contraception.

Eastern China leads the IUD market in 2025, attributed to advanced healthcare infrastructure, high urbanization, and greater accessibility to modern contraceptives. Central China is rapidly catching up as provincial governments invest in women's health and rural outreach initiatives. Western China—while representing a smaller percentage—shows significant potential for growth as new distribution channels and educational programs penetrate less developed areas. Regional disparities are narrowing as public health policies promote national equity in contraceptive access.

Bayer AG continues to dominate the Chinese IUD market, leveraging its extensive product portfolio and strong hospital partnerships. Domestic players like Shanghai Dahua Medical Apparatus are strengthening their position through innovative offerings and competitive pricing. CooperSurgical Inc. and other global brands maintain significant market shares through clinical collaborations and regulatory compliance. The competitive landscape is becoming more dynamic as both foreign and local companies intensify R&D investments and distribution strategies.

Hospitals remain the largest buyers of IUDs in China, supported by robust public procurement programs and doctor-led insertions. Clinics and retail pharmacies are showing rising shares as outpatient adoption of IUDs increases in both urban and suburban settings. With the expansion of digital health, online pharmacies are emerging as a promising buyer group, particularly popular among younger demographics seeking convenience and privacy in contraceptive purchases.

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	790
Regions	Eastern China, Central China, Western China
Segments	By Type: Copper IUDs, Hormonal IUDs, Biodegradable IUDs, Inert IUDs, Dual-Function IUDs, Others; By Application: Contraception, Menorrhagia, Dysmenorrhea, Emergency Contraception, Endometriosis, Others
Players	Bayer AG, OCON Healthcare, CooperSurgical Inc., Pregna International Ltd., Meril Life Sciences Pvt. Ltd., SMB Corporation of India, HLL Lifecare Limited, Shanghai Dahua Medical Apparatus Co. Ltd., Sichuan Qianjin Technology Co. Ltd., DKT International, Sanghai Medical, Hubei XINMA Medical Devices Co. Ltd., Contraceptives India, Lifecare Devices Pvt. Ltd., Other Key Players

June 2024: Bayer AG announced a nationwide partnership with leading private hospitals to implement advanced provider training on next-generation hormonal IUDs.
July 2024: OCON Healthcare received regulatory approval for its biodegradable IUD prototype in major urban centers.
August 2024: DKT International launched a direct-to-consumer marketing campaign with JD Health, strengthening online access to IUD products.
September 2024: Shanghai Dahua Medical Apparatus introduced a copper IUD with improved anti-infection coating at a regional medical technology summit.
October 2024: CooperSurgical Inc. expanded its RFID-enabled smart IUD program to 10 new provincial hospitals in China.

About the Author

Ankita R

Lead Industry Analyst

Ankita R is a Lead Industry Analyst specializing in market research, industry analysis, and business consulting across Medical Devices. Ankita R brings a commercially grounded perspective to sectors shaped by changing demand, innovation, and competitive dynamics, helping turn complex market trends into clear strategic insights for business decision-makers. With 10+ years of experience across research, analytics, and strategic advisory roles, Ankita R has helped organizations translate data into actionable growth strategies.

Medical DevicesMarket ResearchIndustry AnalysisStrategic Consulting

Key Questions Answered

»What is the market size and growth rate of the global and regional market by various segments?
»What is the market size and growth rate of the market for selective countries?
»Which region or sub-segment is expected to drive the market in the forecast period?
»What factors are estimated to drive and restrain the market growth?
»What are the key technological and market trends shaping the market?
»What are the key opportunities in the market?
»What are the key companies operating in the market?
»Which company accounted for the highest market share?

Download Sample

Why Choose Bussiness Insights?

»Strong Industry Focus
»Extensive Product Offerings
»Customer Research Services
»Robust Research Methodology
»Comprehensive Reports
»Latest Technological Developments
»Value Chain Analysis
»Potential Market Opportunities
»Growth Dynamics
»Quality Assurance
»Post-sales Support
»Regular Report Updates

Speak to Analyst

China Intrauterine Devices Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

China Intrauterine Devices Market Outlook (2025-2035)

Latest Market Dynamics

Key Drivers

Key Trends

Key Opportunities

Key Challenges

Key Restraints

China Intrauterine Devices Market Share (%), By Type 2025

China Intrauterine Devices Market Share (%), By Application 2025

China Intrauterine Devices Market Revenue (USD Million), (2020-2035)

China Intrauterine Devices Market YOY (%), (2020-2035)

China Intrauterine Devices Market by Regions Share (%), 2025

China Intrauterine Devices Market Players Share (%), 2025

China Intrauterine Devices Market Buyers Share (%), 2025

Study Coverage

Key Recent Developments

Frequently Asked Questions

About the Author

Related Reports